The Beauty Health Company
SKIN
$2.31
-$0.02-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.70% | -14.52% | -13.76% | -19.11% | -22.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.70% | -14.52% | -13.76% | -19.11% | -22.88% |
| Cost of Revenue | -41.44% | -36.44% | -39.08% | -65.30% | 0.10% |
| Gross Profit | 19.96% | 0.45% | 14.58% | 423.82% | -39.68% |
| SG&A Expenses | -18.31% | -4.70% | -4.46% | -9.83% | -20.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.23% | -17.07% | -21.30% | -44.12% | -13.72% |
| Operating Income | 87.79% | 29.24% | 61.02% | 73.79% | -68.20% |
| Income Before Tax | 12,496.69% | -587.89% | -33.16% | 76.77% | -112.89% |
| Income Tax Expenses | -181.30% | 235.36% | -330.18% | -44.01% | 83.90% |
| Earnings from Continuing Operations | 9,658.42% | -1,386.89% | -9.86% | 75.22% | -94.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9,658.42% | -1,386.89% | -9.86% | 75.22% | -94.00% |
| EBIT | 87.79% | 29.24% | 61.02% | 73.79% | -68.20% |
| EBITDA | 120.47% | 29.77% | 92.87% | 83.86% | -391.21% |
| EPS Basic | 9,675.00% | -1,367.27% | -13.54% | 73.47% | -93.68% |
| Normalized Basic EPS | 103.51% | 48.02% | -37.94% | 76.74% | -1,703.64% |
| EPS Diluted | 129.17% | 15.23% | -8.36% | 73.21% | -502.37% |
| Normalized Diluted EPS | 103.65% | 38.99% | -37.94% | 76.74% | -1,496.36% |
| Average Basic Shares Outstanding | 1.90% | 1.59% | -3.35% | -6.65% | -6.78% |
| Average Diluted Shares Outstanding | -1.15% | -13.43% | -3.35% | -6.65% | 6.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |